Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
12/17/2008 | CN101322791A Chinese medicine for treating chronic anemia |
12/17/2008 | CN101322737A Persimmon leaf flavones extract and preparation thereof |
12/17/2008 | CN101322735A Optimizing method for attenuation processing of Tripterygium wilfordii and related formulation |
12/17/2008 | CN101322684A Acetic acid desmopressin injection prescription and preparation technique thereof |
12/17/2008 | CN100443499C High purity albumin production process |
12/17/2008 | CN100443485C Derivative of soldium iron chlorophyllin, preparation method and application |
12/17/2008 | CN100443477C Substituted benzoxazoles and analogues as estrogenic agents |
12/17/2008 | CN100443472C 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
12/17/2008 | CN100443092C Granulocyte raised drug comprising cepharanthine |
12/16/2008 | US7465820 Abiotic heparin antagonists |
12/16/2008 | US7465713 human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; 3-(6-O-ethoxycarbonyl- beta -D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methy]-1-isopropyl-5-methylpyrazole |
12/16/2008 | US7465548 associated with the disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, urological diseases, respiratory diseases and gastroenterological diseases |
12/16/2008 | CA2285242C Mixture of primary fatty acids obtained from sugar cane wax |
12/11/2008 | WO2008151288A2 Aromatic and heteroaromatic compounds useful in treating iron disorders |
12/11/2008 | WO2008150246A1 Herbal haemostatic composition |
12/11/2008 | WO2008150196A1 Oxygen-transferring blood substitute |
12/11/2008 | WO2008149788A1 Solid dialysis preparation |
12/11/2008 | WO2008148359A1 The therapeutic uses of imidazol-5-carboxylic acid derivatives |
12/11/2008 | WO2008113863A3 Nitrosated derivatives of 2,5-dihydroxybenzene compounds |
12/11/2008 | WO2008082321A8 Emulsion of perfluoroorganic compounds for medical use and a methods for the preparation and the use thereof |
12/11/2008 | US20080306278 Process |
12/11/2008 | US20080306263 Process For The Preparation Of Optically Pure Tetrahydropterins And Derivatives, And Specifically Of Optically Pure Tetrahydrofolic Acid And Derivatives Thereof, By Stereospecific Hydrogenation |
12/11/2008 | US20080306145 Preparation Of Ginkgolide And F-Seco-Ginkgolide Lactols |
12/11/2008 | US20080306118 Process for the crystallization of (R) - or (S) - Lansoprazole |
12/11/2008 | US20080306113 Methods for treating macular degeneration using 4-(amino)-2-(2,6-dioxo(3-piperidyle))-isoindoline-1,3-dione |
12/11/2008 | US20080306065 Metalloproteinase Inhibitors |
12/11/2008 | US20080305992 Glycopegylated erythropoietin |
12/11/2008 | US20080305178 Use of a high molecular weight extracellular haemoglobin as a blood substitute |
12/11/2008 | US20080305163 Butylphthalide soft gel capsule and its preparation procedure |
12/11/2008 | US20080305156 Echogenic Vehicle for Clinical Delivery of Plasminogen Activator and Other Fibrin-Binding Therapeutics to Thrombi |
12/11/2008 | US20080305146 Selective cell therapy for the treatment of renal failure |
12/11/2008 | US20080305110 Novel Ligand of G Protein Coupled Receptor Protein and Use Thereof |
12/11/2008 | US20080305074 Stem cell factor |
12/11/2008 | CA2688547A1 Aromatic and heteroaromatic compounds useful in treating iron disorders |
12/10/2008 | EP2000540A2 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer |
12/10/2008 | EP2000465A1 Triazolone derivative |
12/10/2008 | EP1998778A1 Use of (s)-roscovitine for manufacturing a medicine |
12/10/2008 | EP1492501B1 Methods of using lamellar bodies for therapeutic purposes |
12/10/2008 | EP1467735B1 Polymorphs of clopidogrel hydrogensulfate |
12/10/2008 | EP1274450B1 Medical uses of agonsist and antagonists of IL-174 |
12/10/2008 | EP1066056B2 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition |
12/10/2008 | CN101321870A Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
12/10/2008 | CN101321520A Slow-release composition, method for the preparation thereof, and use of the same |
12/10/2008 | CN101319207A Site-directed mutagenesis genetic engineering batroxobin and uses thereof |
12/10/2008 | CN101319186A Preparation method for Chinese rose brandy for female |
12/10/2008 | CN101319013A Low-numerator sulphuric acid rhamnosan, preparation and application thereof |
12/10/2008 | CN101318995A Substituted tetrahydro-isoquinoline isoquinolinium compound, preparation method and application thereof |
12/10/2008 | CN101318994A Substituted tetrahydro-isoquinoline-3-carboxylic acid compound, preparation method and application thereof |
12/10/2008 | CN101318993A Hybridized peptide with 3S-tetrahydrochysene-beta-carboline-3-carboxylic acid as connecting arm, preparation method and application thereof |
12/10/2008 | CN101318992A Complete-basic amino acid oligopeptide, copper complex, synthesis method, self-assembly and application thereof |
12/10/2008 | CN101318968A Benzoxazine-pyrazoles and opened loop compound |
12/10/2008 | CN101318933A Isoquinolinium compounds with antithrombotic activity, preparation method and application thereof |
12/10/2008 | CN101318010A Method for preparing capsule for warming Yang, enlivening spleen and activating qi to excrete water |
12/10/2008 | CN101317950A Method for preparing capsule for benefitting qi, nourishing blood, nourishing heart and pacifying the mind |
12/10/2008 | CN101317949A Method for preparing capsule for nourishing blood, regulating menstruation and nourishing blood and liver |
12/10/2008 | CN101317929A Method for preparing capsule for warming yang, tonifying qi, and promoting defecation |
12/10/2008 | CN101317919A Method for preparing blood-nourishing hair tonic capsule |
12/10/2008 | CN101317916A Medicament for treating metrorrhagia and metrostaxis and preparation method thereof |
12/10/2008 | CN101317886A Process for preparing capsule for nourishing blood |
12/10/2008 | CN101317869A Method for extracting flavone from capillary wormwood |
12/10/2008 | CN101317855A Autologous or homologous coagulant produced from anticoagulated whole blood |
12/10/2008 | CN101317680A Safflower (solid) beverage |
12/10/2008 | CN101317676A Puffed food made of sacred lotus husk |
12/10/2008 | CN100441595C Novel peptides that bind to the erythropoietin receptor |
12/10/2008 | CN100441594C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
12/10/2008 | CN100441225C Amino-acid modified chitin nucleophic NO donor and its synthesis method |
12/10/2008 | CN100441204C Process for preparing fresh motherwort formulation |
12/10/2008 | CN100441171C Dispersible tablet for treating blood syndrome, its preparation method and purposes |
12/09/2008 | US7462643 Essential fatty acids in the prevention of cardiovascular events |
12/09/2008 | US7462635 e.g. 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-[3-(2-methylphenoxy)propyl]oxazole; voltage-dependent anion channel, mitochondria porin modulator, apoptosis suppressor, mitochondria function ameliorator; Down syndrome, pigmentary degeneration of retina, alcoholic hepatitis or sideroblastic anemia |
12/09/2008 | US7462592 Compositions and methods for polynucleotide delivery |
12/09/2008 | CA2453946C Process for the preparation of 3-spiro[cyclohexam-1,3'-[3h]indolin-2'-one] derivatives |
12/09/2008 | CA2415447C Novel .gamma. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same |
12/09/2008 | CA2388142C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
12/09/2008 | CA2352054C New amidino derivatives and their use as thrombin inhibitors |
12/09/2008 | CA2337804C Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions |
12/09/2008 | CA2294059C New amidino derivatives and their use as thrombin inhibitors |
12/04/2008 | WO2008146249A1 Processes for the preparation of clopidogrel |
12/04/2008 | WO2008145281A2 Formulations containing triazinones and iron |
12/04/2008 | WO2008099144A3 Tgf-beta stimulant and further agent to reduce side effects |
12/04/2008 | WO2008024277A3 Kw-3902 conjugates that do not cross the blood-brain barrier |
12/04/2008 | US20080300247 Benzimidazole Thiophene Compounds |
12/04/2008 | US20080300218 Crosslinkable polysaccharide derivative, process for producing the same, crosslinkable polysaccharide composition, and medical treatment material |
12/04/2008 | US20080300175 Glycopegylated erythropoietin |
12/04/2008 | US20080300174 Compositions and methods for enhancing factor viii heavy chain secretion |
12/04/2008 | US20080299224 Resuscitation fluid |
12/04/2008 | US20080299221 Method for Decreasing Postprandial Glucose Excursion |
12/04/2008 | US20080299134 Recombinant Anti-Interleukin-9 Antibodies |
12/04/2008 | US20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof |
12/04/2008 | US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene |
12/04/2008 | US20080299071 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
12/04/2008 | CA2688613A1 Formulations containing triazinones and iron |
12/03/2008 | EP1997829A1 Albumin fusion proteins |
12/03/2008 | EP1997505A1 Erythropoietin solution preparation |
12/03/2008 | EP1997494A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto |
12/03/2008 | EP1996626A1 Anti-idiotypic antibody which neutralizes the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii |
12/03/2008 | EP1996541A1 2-(aryloxy)acetamide factor viia inhibitors useful as anticoagulants |
12/03/2008 | EP1511499B1 Immunomodulatory compounds and methods of use thereof |
12/03/2008 | CN101316853A Oxazolopyridine derivatives as SIRTUIN modulators |
12/03/2008 | CN101316599A Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of NKT cell as active ingredient |